← Open Payments lookup

CHARLES BRAMLET: Open Payments

NPI 1457438947 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$554 in 27 payments from 13 companies in 2025. Trend: 2023 $586 · 2024 $565 · 2025 $554

Food & beverage: $554
CompanyPaymentsAmount
Noven Therapeutics, LLC9$188
Alkermes, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.3$61
Vanda Pharmaceuticals Inc.2$52
ABBVIE INC.2$37
Corium, LLC1$26
Otsuka America Pharmaceutical, Inc.1$24
Vertical Pharmaceuticals, LLC1$21
Teva Pharmaceuticals USA, Inc.1$20
Collegium Pharmaceutical, Inc.1$19

Products named: Xelstrym, ARISTADA, TRINTELLIX, FANAPT, VRAYLAR, Azstarys, REXULTI, Relexxii.

Industry payments across LA — which companies pay providers there.